Sign in to view content

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

David M. Brown, MD

Video
Published 2021

Related

VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019
Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Outcomes of Intravitreal Antivascular Endothelial Growth Factor (VEGF) Therapy for Diabetic Macular Edema in Routine Clinical Practice
John D Pitcher, MD
Annual Meeting Talks
2018

Category: Pharmacology

See more